CAPR vs TJX · $1.62B cap vs P/E 32, rev $29.50B
Capricor Therapeutics Inc (CAPR) versus The TJX Companies Inc (TJX) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
CAPR currently screens at market cap $1.62B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Not investment advice. Open the CAPR and TJX stock pages for the full models.
Not investment advice.